673 results on '"Borer, Jeffrey S"'
Search Results
2. Effect of Left Ventricular Conduction Delay on All-Cause and Cardiovascular Mortality (from the PRECISION Trial)
3. Sample Size Requirements for Clinical Trials of Transcatheter Valve Replacement and Valve Repair Devices
4. Effect of Aspirin Coadministration on the Safety of Celecoxib, Naproxen, or Ibuprofen
5. Cardiac Resynchronization Therapy in Patients With Heart Failure and Narrow QRS Complexes
6. The Risk of Major NSAID Toxicity with Celecoxib, Ibuprofen, or Naproxen: A Secondary Analysis of the PRECISION Trial
7. Efficacy of ivabradine in heart failure patients with a high‐risk profile (analysis from the SHIFT trial).
8. Comparison of Outcome Adjudication by Investigators and by a Central End Point Committee in Heart Failure Trials: Experience of the SHIFT Heart Failure Study
9. Medical Misinformation: Vet the Message!
10. Benefits of Heart Rate Slowing With Ivabradine in Patients With Systolic Heart Failure and Coronary Artery Disease
11. Misconceptions and Facts About Mitral Regurgitation
12. Update on ivabradine for heart failure
13. Influence of Cardiovascular and Noncardiovascular Co-morbidities on Outcomes and Treatment Effect of Heart Rate Reduction With Ivabradine in Stable Heart Failure (from the SHIFT Trial)
14. Repeated Heart Rate Measurement and Cardiovascular Outcomes in Left Ventricular Systolic Dysfunction
15. Meta-Analysis of the Relation of Body Mass Index to All-Cause and Cardiovascular Mortality and Hospitalization in Patients With Chronic Heart Failure
16. Top ten risk factors for morbidity and mortality in patients with chronic systolic heart failure and elevated heart rate: The SHIFT Risk Model
17. Resting Heart Rate: Risk Indicator and Emerging Risk Factor in Cardiovascular Disease
18. Surgical Treatment of Ischemic Mitral Regurgitation: Valve Repair Versus Replacement
19. Risk of Atrial Fibrillation With Use of Oral and Intravenous Bisphosphonates
20. Efficacy and Safety of Ivabradine in Patients With Severe Chronic Systolic Heart Failure (from the SHIFT Study)
21. Duration of chronic heart failure affects outcomes with preserved effects of heart rate reduction with ivabradine: findings from SHIFT
22. Impact of Beta-Blockade on Cardiac Events in Patients with Chronic Severe Nonischemic Mitral Regurgitation
23. Abstract 18347: Prognostic Significance of Activation Delay by Cross Correlation Analysis Using Tissue Doppler Imaging in Patients With Heart Failure and Narrow QRS Duration; an Echocardiography Guided Cardiac Resynchronization Therapy (Echo-CRT) Trial Substudy of Patients Not Randomized to CRT
24. Abstract 15937: Abnormal Left Ventricular Conduction is Associated With Increased Cardiovascular Mortality Compared to Abnormal Right Ventricular or Normal Conduction: Insights From the Precision Trial
25. Abstract 14007: Advancing Age is a Stronger Predictor of Increasing Valvular Heart Disease Hospitalizations Than Variations in Gender, Race or Ethnicity
26. Selective Heart Rate Reduction With Ivabradine Unloads the Left Ventricle in Heart Failure Patients
27. Usefulness of Preoperative Exercise Tolerance to Predict Late Survival and Symptom Persistence After Surgery for Chronic Nonischemic Mitral Regurgitation
28. Efficacy Profile of Ivabradine in Patients with Heart Failure plus Angina Pectoris
29. Effect of cardiac resynchronization therapy in patients with diabetes randomized in EchoCRT
30. Challenges to Data Monitoring Committees When Regulatory Authorities Intervene
31. Association of persistent or worsened echocardiographic dyssynchrony with unfavourable clinical outcomes in heart failure patients with narrow QRS width: a subgroup analysis of the EchoCRT trial
32. Efficacy and safety of ivabradine in patients with chronic systolic heart failure and diabetes: an analysis from the SHIFT trial
33. Heart Rate, Life Expectancy and the Cardiovascular System: Therapeutic Considerations
34. Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial
35. Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study
36. Efficacy of Ivabradine, a Selective If Inhibitor, in Patients With Chronic Stable Angina Pectoris and Diabetes Mellitus
37. The effect of QRS duration on cardiac resynchronization therapy in patients with a narrow QRS complex: a subgroup analysis of the EchoCRT trial
38. Clinical trial design principles and endpoint definitions for transcatheter mitral valve repair and replacement: part 1: clinical trial design principles: A consensus document from the mitral valve academic research consortium
39. Effect of Combining Ivabradine and β-Blockers: Focus on the Use of Carvedilol in the SHIFT Population
40. Twenty-four-hour heart rate lowering with ivabradine in chronic heart failure: insights from the SHIFT Holter substudy
41. Acceptability and Psychometric Properties of the Minnesota Living With Heart Failure Questionnaire Among Patients Undergoing Heart Valve Surgery: Validation and Comparison With SF-36
42. Evaluation of the Relationship Between Serum Urate Levels, Clinical Manifestations of Gout, and Death From Cardiovascular Causes in Patients Receiving Febuxostat or Allopurinol in an Outcomes Trial.
43. Relation of Indirect Vasodilator Use to Prognosis in Patients with Chronic Severe Mitral Regurgitation
44. Role of Oral Factor Xa Inhibitors after Acute Coronary Syndrome
45. Trials of implantable monitoring devices in heart failure: which design is optimal?
46. Heart rate reduction in cardiovascular disease and therapy
47. Efficacy and safety of ivabradine in patients with chronic systolic heart failure according to blood pressure level in SHIFT
48. Heart rate: a prognostic factor and therapeutic target in chronic heart failure. The distinct roles of drugs with heart rate-lowering properties
49. Drug-induced valve disease and considerations of benefit versus risk
50. Efficacy and safety of ivabradine in chronic heart failure across the age spectrum: insights from the SHIFT study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.